Navigation Links
Latest Salvo Fired in Frozen Yogurt Wars as Southern California's Fastest-Growing Franchise - Cefiore - Launches New Chocolate Flavor
Date:2/12/2008

$22 Billion Industry and 12% Growth of Frozen Desserts Nationwide Fuels

Cefiore's Surge

CITY OF INDUSTRY, Calif., Feb. 12 /PRNewswire/ -- Cefiore, Southern California-based and one of the nation's fastest-growing frozen yogurt destinations, introduced today its new chocolate flavor, just in time for Valentine's Day. With more than 90% of U.S. households consuming frozen desserts and many choosing frozen yogurt as their preferred option, Cefiore has emerged as a cult favorite and increasingly popular healthy treat alternative.

The launch of Cefiore Chocolate, the company's second new flavor introduction in recent months (following the launch of Acai Berry in November), further establishes Cefiore as one of the most innovative frozen yogurt companies throughout the U.S. The new Cefiore Chocolate flavored frozen yogurt offers a healthy alternative for chocolate lovers. Unlike traditional frozen yogurt, Cefiore's new chocolate flavor is light and creamy, low in sugar and calories, and has zero fat.

"Since first opening our doors in 2006, we have seen huge growth in the frozen yogurt business," said Danny Kim, vice president, Cefiore. "With more consumers craving better-for-you desserts, we developed our Cefiore chocolate flavor to meet customer demand."

The company has gone head-to-head with Pinkberry over the last year, but has gained a strong edge in the market, continuing to sell franchises while the competition has stopped.

Cefiore boasts approximately 25 locations, with dozens more planned for 2008 throughout the United States, along with expansion into Canada, Australia and China.

About Cefiore

Cefiore is one of the leading frozen yogurt companies in Southern California. Since first opening its doors in 2006, Cefiore has already grown steadily throughout California and other areas of the nation. The company has built a strong following for its unique and refreshing non-fat frozen
'/>"/>

SOURCE Cefiore
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Cejka Search Experts Present Latest Developments in Physician Retention and CEO Leadership Skills
2. Teens, Young Adults Missing Out on Latest Cancer Advances
3. Latest Study Says Statins Dont Slow Alzheimers
4. Cancer study finds adolescents dont get same access to latest treatments as younger patients
5. Statement from AAJ President Kathleen Flynn Peterson on ATRAs Latest Attack on Civil Justice Attorneys
6. A Whole New Sandwich Debuts in the Freezer Aisle: LEAN POCKETS(R) Brand Introduces Latest Whole Grain Varieties
7. AST Emergence to Convergence Highlights the Latest High-Risk Organ Donor and Recipient Issues
8. Latest Edition of Ripon Forum Highlights Schwarzeneggers Leadership on Another Challenge Facing his State - Health Care
9. Cejka Search Experts Present Latest Developments in Physician and Healthcare Employment at Leading Industry Conferences
10. The latest about male infertility and testosterone from NewYork-Presbyterian/Weill Cornell
11. Actor Joe Pantoliano Discloses Depression; Talks About His Latest Movie and His Sensitive Side
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/26/2008)...team develops device giving patients freedom of mo...DAY, July 26 (HealthDay News) -- An automated arti...e day be to dialysis patients what the insulin pum...rable artificial kidney (AWAK) works better than c...current issue of Clinical and Experimental Nephro...
(Date:7/25/2008)...AKE SUCCESS, N.Y., July 25 /PRNewswire-USNewswire/...as Chief Quality Officer and Vice President,of Str...monwealth Fund, a,national foundation committed to...e directed the foundation,s Program on Health Care...p://www.newscom.com/cgi-bin/prnh/20080725/DC28791L...
(Date:7/25/2008)...red immune response after antiretroviral therapy m... July 25 (HealthDay News) -- A new study challenge...(HCV) impairs the immune system,s ability to resto...ly active antiretroviral therapy (HAART). , Fro...ers are also infected with HCV. Intravenous drug u...
(Date:7/25/2008)...he Authority offers patients consumers tips and en...ient safety, HARRISBURG, Pa., July 25 /PRNewswire...thority today supports "National Patient Safety Da...s and their families to,participate fully in their...thing they can about their surgery or illness., "...
Breaking Medicine News(10 mins):Health News:IPRO Welcomes Back Anthony Shih as Chief Quality Officer, Strategic Planning Lead 2Health News:Study Disproves Belief That Hepatitis C Blunts HIV Drugs 2Health News:Patient Safety Authority Supports 'National Patient Safety Day' 2Health News:Patient Safety Authority Supports 'National Patient Safety Day' 3
...ngton, in Seattle, a group of engineers has recent... latest creation: a surgical robot// to deploy in ... a remote control console. Military groups all ov... in remote surgery. On the battlefield, medical re...
...Children's Research Hospital have discovered that ...duction of a molecule that is key to the ability//...s to break down toxins, and of cells to extract en...estigators showed that ABCB6 is lodged within the ...
...ide rates among younger and older Americans have b...ling news: No one really knows why// . Those are ...t the University of South Carolina and released Th...tober issue of the American Journal of Public Heal...
...lty members performing microsurgery in Tanzania fr...om, or health care experts// in Vietnam presenting...thered in the Hopkins outpatient center. These are... Internet communication system that will be used f...
Other Medicine News:Health News:Doc at a Distance 2Health News:ABCB6 Is Key to Production of Heme in Hemoglobin 2Health News:Most Suicide Rates Decline, but Findings Are Puzzling 2Health News:Most Suicide Rates Decline, but Findings Are Puzzling 3Health News:High-Speed Internet2 Link Revolutionizes Global Medical Education 2
(Date:7/24/2008)... /PRNewswire-USNewswire/ -- Headlines claiming "so...e story. The small scale,preliminary study that D...duction, is based on recollected intake of soyfood...This study is confounded by many,issues, thus I fe...of,caution," warned Dr. Tammy Hedlund, a researche...
(Date:7/24/2008)...rance, July 24 /- NicOx S.A...ne results from the 52-week,open label safety exte...of,the 301 phase 3 study for naproxcinod. The resu...icacy was maintained for the one-year duration of,...essment scale. In,addition, the results showed tha...
(Date:7/23/2008)... /PRNewswire-USNewswire/ -- The following was,rele... Conyers, Ranking Member Smith, and Members of the...fy today., Since I appeared before this Committee...acquainted with the talented and dedicated profess... they do, and I have come to,appreciate that much ...
(Date:7/23/2008)...RNewswire-FirstCall/ -- Dendreon Corporation,(Nasd...dependent Data,Monitoring Committee (IDMC) to revi... survival relating to the Company,s Phase 3 IMPACT...ent, also known as D9902B) clinical trial,of PROVE...nvestigational,active cellular immunotherapy for t...
Breaking Medicine Technology:Soyfoods Do Not Impact Sperm Count 2NicOx Announces Top-Line Results From Naproxcinod 52-Week 301 Safety Extension 2NicOx Announces Top-Line Results From Naproxcinod 52-Week 301 Safety Extension 3NicOx Announces Top-Line Results From Naproxcinod 52-Week 301 Safety Extension 4Prepared Remarks of Attorney General Michael B. Mukasey Before the House Judiciary Committee 2Prepared Remarks of Attorney General Michael B. Mukasey Before the House Judiciary Committee 3Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 2Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 3Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 4Steps toward Stopping Autoimmune Disease 1967 1Steps toward Stopping Autoimmune Disease 1967 2CeloNova BioSciences Announces Positive Results from European Study of Embozene 28TM 29 Microspheres for Treatment of Uterine Fibroids 1229 1CeloNova BioSciences Announces Positive Results from European Study of Embozene 28TM 29 Microspheres for Treatment of Uterine Fibroids 1229 2Students Pursuing Health Care Careers Receive 2424 000 in Scholarships From National Hispanic Health Foundation 9799 1Students Pursuing Health Care Careers Receive 2424 000 in Scholarships From National Hispanic Health Foundation 9799 2Solutions for Parents Who Need Cold Remedies for Their Children 9795 1Solutions for Parents Who Need Cold Remedies for Their Children 9795 2
...EGO, May 22, 2007 /PRNewswire/ -- A new study pres...iddle-of-the-night,balance, mobility or memory per...o placebo. This study also demonstrated, as in,pre... did have,impaired performances on these measures,...e-blind, placebo-controlled trial were,presented i...
... Release of Data for New Combination , , , , , P...cium channel blocker,amlodipine besylate with the ... produced significant mean reductions in,seated sy...th,hypertension, according to data presented at th...Second Annual Scientific Meeting and,Exposition (A...
Other Medicine Technology:New Study Suggests no Significant Impairment in Middle-of-the-Night,Balance, Mobility or Memory in Older Adults Using Ramelteon 2New Study Suggests no Significant Impairment in Middle-of-the-Night,Balance, Mobility or Memory in Older Adults Using Ramelteon 3New Study Suggests no Significant Impairment in Middle-of-the-Night,Balance, Mobility or Memory in Older Adults Using Ramelteon 4Amlodipine and Olmesartan Study Results Released;Late Breaker,Presented at American Society of Hypertension Twenty-Second Annual,Scientific Meeting (ASH 2007) 2Amlodipine and Olmesartan Study Results Released;Late Breaker,Presented at American Society of Hypertension Twenty-Second Annual,Scientific Meeting (ASH 2007) 3Amlodipine and Olmesartan Study Results Released;Late Breaker,Presented at American Society of Hypertension Twenty-Second Annual,Scientific Meeting (ASH 2007) 4
Meter Trax Control is a whole blood quality control that can be used for glucose, hemoglobin and hematocrit testing on point of care instruments.
Liquichek Qualitative Urine Toxicology Control is a liquid control designed for use with qualitative rapid urine drug screen panels, including Point of Care (POC) Drugs of Abuse (DOA) test kits like
Liquichek Sedimentation Rate Control is a bilevel human whole blood based control designed to monitor both manual and automated methods for measuring erythrocyte sedimentation rates.
Liquichek Hematology-16 Control is specifically designed for use on most hematology analyzers that measure up to 16 parameters and 3-part white blood cell differentials. This trilevel control can be
Medicine Products: